Reuters logo
BRIEF-Basilea completes license agreement with Pfizer for Cresemba
July 20, 2017 / 5:24 AM / 4 months ago

BRIEF-Basilea completes license agreement with Pfizer for Cresemba

July 20 (Reuters) - BASILEA PHARMACEUTICA AG:

* BASILEA ANNOUNCES COMPLETION OF THE LICENSE AGREEMENT WITH PFIZER FOR ANTIFUNGAL CRESEMBA® FOR EUROPE, RUSSIA, TURKEY AND ISRAEL

* ‍AGREEMENT GRANTS PFIZER RIGHT TO MANUFACTURE ISAVUCONAZOLE AND TO EXCLUSIVELY COMMERCIALIZE DRUG IN EUROPE (EXCLUDING NORDICS), RUSSIA, TURKEY AND ISRAEL​

* ‍BASILEA WILL RECEIVE AN UPFRONT PAYMENT OF CHF 70 MILLION​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below